Home » Topics » Regulatory » Patents

Patents
RSS

Eisai discloses IL-1 inhibitors

Jan. 23, 1997

Inhibitors of alpha-amylase disclosed by Japanese researchers

Jan. 23, 1997

MAb from Hayashibara with IFN-inducing properties

Jan. 23, 1997

Raloxifene for inhibition of vascular smooth muscle cell migration

Jan. 23, 1997

Glaxo Wellcome claims new formulation of anxiolytic agent

Jan. 23, 1997

New antiasthma agents from Tanabe Seiyaku

Jan. 23, 1997

5-HT3/5-HT4 receptor ligands disclosed by Synthelabo

Jan. 23, 1997

SmithKline Beecham reports new antiinflammatory/antiallergic agents

Jan. 23, 1997

New COX-2 inhibitor series disclosed by Merck Frosst

Jan. 23, 1997

ACAT inhibitors from Takeda

Jan. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.